A new study using WHI data found that hormone therapy decreases markers of insulin sensitivity and blood glucose in women, reducing the risk of Type 2 diabetes. The study focused on nine metabolites associated with diabetes development and found seven to be significantly decreased with hormone therapy.
A study by The World Cancer Research Fund and the American Institute for Cancer Research suggests that lifestyle modifications can prevent up to 30% of breast cancer cases. The recommended modifications include maintaining a healthy weight, engaging in regular physical activity, and consuming a balanced diet rich in non-starch vegetables.
A new study finds that night sweats are associated with decreased attention and executive function in menopausal women, even as total sleep time increases. In contrast, daytime hot flashes have no impact on sleep duration.
A new study associates self-silencing with greater carotid plaque buildup, which could lead to a stroke and other cardiovascular problems. Women who do not express their feelings are at increased risk of cardiovascular issues.
A new study finds that waist size, not overall obesity, is a significant predictor of coronary artery disease in postmenopausal women. The study, published in Menopause, found no association between body mass index and obstructive cardiovascular disease.
A new study confirms that women with type 2 diabetes are at greater risk for sleep disturbances during the menopause transition. The study found a significant association between diabetes and increased severity of sleep-related symptoms, particularly in Asian women.
A new study demonstrates the effectiveness of cognitive behavior therapy in managing common menopause symptoms. The treatment significantly improved hot flashes, depression, and sleep disturbances, while also providing long-term benefits.
A new study of over 25,000 women from the Women's Health Initiative trials found that those experiencing persistent vasomotor symptoms are more likely to be diagnosed with breast cancer. The study also identified other risk factors, including high body mass index and current alcohol use.
A new study involving over 300 women reveals a strong association between sexual harassment and assault with higher blood pressure, depression, anxiety, and poor sleep quality. The findings suggest that the experience of sexual harassment and assault can have lasting impacts on women's health.
A new study suggests that higher mindfulness may lower stress and the impact of menopause-related symptoms such as hot flashes in midlife women. The study, presented at The North American Menopause Society Annual Meeting, found a correlation between higher mindfulness and lower menopause symptom scores, as well as lower stress scores.
A recent symposium will review the current criteria for diagnosing Alzheimer's disease, highlighting the need to rethink diagnostic approaches. The event also explores how brain metabolism changes in women after menopause may increase their risk of developing Alzheimer's.
New hormone and non-hormone options are available to help women maintain a healthy sex life during menopause. Topical lidocaine, pelvic floor therapy, and vaginal laser therapy show promise in reducing pain and friction.
A new study based on SWAN data suggests that women with a history of hypertensive disorders of pregnancy and gestational diabetes may experience a greater burden of hot flashes during the menopause transition. The study identified social factors such as education as influential in shaping pregnancy outcomes and hot flashes.
Researchers discuss historical and current evidence-based approaches to stimulating female sexual desire, highlighting the role of dopamine and music in enhancing pleasure. The study aims to improve healthcare providers' understanding of women's sexual health, particularly those affected by hypoactive sexual desire disorder.
Research suggests that women's reproductive health, hormones, and mental health play a crucial role in maintaining telomere length and slowing the aging process. Dr. Elissa Epel's presentation highlights the importance of estrogen's protective effects on telomeres and heart disease.
According to Dr. Holly Pederson, genetic testing can help identify patients at risk of breast cancer and reduce their chances of survival. The presentation highlights the importance of early screening and advances in cancer genetics, making it possible to save lives through preventive medications and surgical procedures.
A new study from the University of California found that light therapy can alter circadian rhythms and sleep/wake cycles, leading to improved mood and sleep in perimenopausal women. This non-pharmacological treatment option may provide symptomatic relief for those struggling with depression and sleep problems.
A new study compares interferential current to vaginal estradiol creme in treating sexual complaints of women with premature ovarian insufficiency taking hormones. Interferential current improves lubrication, pain, orgasm, and overall satisfaction.
A new study, based on a subgroup of KEEPS participants, found no effects of hormone therapy cessation on carotid artery intima-media thickness. The results support the use of hormone therapy for menopause symptom relief or bone loss prevention, with potential benefits on heart disease reduction.
A new study finds that hysterectomies with ovarian conservation increase the risk of hyperlipidemia, hypertension, and cardiovascular disease. Women under 35 are at greatest risk for congestive heart failure and coronary artery disease.
A new study reveals lingering misperceptions about hormone therapy (HT) among clinicians are preventing women from benefiting from treatment. Despite evidence suggesting HT is a relatively safe solution for symptomatic menopausal women, the number of prescriptions and uses continues to decline due to skepticism.
New research highlights same-sex attraction as changing over time, with some women experiencing changes in sexual orientation later in life. Experts stress the importance of open dialogue between patients and healthcare providers about lifestyle changes.
A recent presentation highlights the need for individualized assessment based on patient characteristics and risk factors to diagnose postmenopausal bleeding. The standard diagnostic approach has changed over the past 25 years, but no single method is suitable for all patients.
Long-term treatment of osteoporosis is crucial for postmenopausal women to reduce fracture risk. New guidelines recommend reevaluating fracture risk after 3-5 years of bisphosphonate treatment and considering alternative therapies or continued treatment.
A new study found that postmenopausal women with vulvovaginal atrophy and lower urinary tract problems experience reduced sexual activity due to painful sex. Fear of pain during sex is a common reason for avoiding intimacy.
A new study finds that traumatic experiences can affect vascular health and increase the risk of heart disease in women, particularly during the menopause transition. Researchers analyzed data from 272 peri- and postmenopausal nonsmoking women and found a link between higher lifetime traumatic experiences and poorer endothelial function.
A new study found that cognitive behavioral therapy significantly improves sleep quality and reduces depressive symptoms in menopausal women. The four-session intervention led to clinically meaningful improvements, regardless of the severity of depression.
A new study suggests that transdermal estradiol therapy can effectively treat and prevent perimenopausal depression. Women experiencing more stressful life events showed the greatest improvements in mood. The study's findings highlight the potential of transdermal estradiol as a preventive measure for perimenopausal depression.
A new study confirms that postmenopausal women prefer less proven options to hormone therapy for treating debilitating symptoms like hot flashes. Women are more willing to use exercise and herbal supplements over hormone therapy, despite acknowledging its effectiveness.
A new study confirms vaginal estrogen is effective in managing sexual and urinary problems of menopause without increasing risk of serious health issues like heart disease and cancer. The WHI data review also clears the use of vaginal estrogen for genitourinary syndrome of menopause.
A new study analyzing Women's Health Initiative (WHI) data found no significant association between migraines and cardiovascular disease events, or an increased risk of heart disease with hormone therapy. Hormone therapy remains a viable treatment option for menopause symptoms in women with migraines.
A new study reveals that anxiety in postmenopausal women is associated with increased severity of physical symptoms like hot flashes and sleep disruption. The study found a significant link between anxiety and urogenital symptoms, highlighting the importance of screening for anxiety to improve quality of life.
A study published by The Menopause Society confirms electro-acupuncture's effectiveness in reducing hot flash severity and improving sleep quality in breast cancer survivors. Electro-acupuncture has been shown to affect neurotransmitters associated with sleep, such as serotonin and melatonin.
A new study using SWAN data shows that black women experience a lower decline in sexual function compared to white and Japanese women during the menopause transition. After the final menstrual period, sexual function scores decreased by 0.35 annually for five years, with smaller declines in black women and larger declines in Japanese w...
A new study analyzing WHI clinical trials data found that women entering menopause before age 40 have a significantly higher fracture risk. Despite using calcium and vitamin D supplements, the risk remains elevated even with hormone therapy.
A study published by The North American Menopause Society found that low-dose estrogen therapy reduced moderate to severe hot flashes and night sweats by 28.3%, 7.4% and 4.2% respectively after 6 months, with sustained improvement over 4 years.
A new survey reveals that most postmenopausal women are unaware of vaginal atrophy (VVA), a chronic progressive condition causing urinary problems. Women are reluctant to discuss symptoms with their healthcare providers, hindering effective treatment.
A study of 124,379 postmenopausal women found that shorter and longer reproductive spans increase the risk of type 2 diabetes. Women with optimal reproductive durations had lower BMI and waist circumferences compared to those with shorter or longer periods.
A study of 3,302 women transitioning through menopause found associations between VMS patterns and demographic, reproductive hormone, and psychosocial factors. Women with early onset VMS were more likely to have elevated depressive symptoms and poorer health.
In a 24-week study, aerobic exercise training improved cardiopulmonary functional capacity and reduced waist circumference in postmenopausal women with nonalcoholic fatty liver disease. Exercise also increased high-density lipoprotein cholesterol levels, but did not significantly affect body composition or glycemic profiles.
A Swedish population study found that estrogen-only therapy carries a lower risk of blood clots than combined estrogen-progestogen therapy. Transdermal estrogen and vaginal estrogen also show no significantly increased risk of blood clots.
A randomized controlled trial found that physical therapy significantly improves urinary incontinence in postmenopausal women with osteoporosis, reducing urine leaks by 75%. The treatment involved pelvic floor muscle exercise and retraining with biofeedback.
A large study of over 6,000 Latin American women found that sedentary lifestyles are associated with severe menopause symptoms, depression, anxiety, insomnia, and obesity. Regular physical activity reduces the risk of various health problems, including breast and colon cancer, dementia, and heart disease.
In a phase III trial, DHEA showed significant improvements in vaginal discomfort after menopause, reducing pain with sex by 0.36 points and improving vaginal dryness by 0.27 points compared to a placebo. The treatment also led to increased superficial cells and decreased parabasal cells, indicating improved vaginal health.
The number of compounded hormone therapy prescriptions has reached 26-33 million a year, with sales expected to continue growing despite potential risks. The lack of clinical data and quality control concerns over these products is alarming.
Overweight and obesity are strong predictors of metabolic syndrome in menopausal women. Women who experienced menopause during the study had a higher risk if they were overweight or obese, with risks increasing by up to 12 times for those who were obese.
A study published in Menopause journal found that over half of women after menopause experience vulvovaginal symptoms, affecting lifestyle and sex life. Nearly a third haven't seen a gynecologist in two years, while most aren't receiving standard treatment for genitourinary syndrome of menopause.
A new study suggests that perimenopausal hormonal fluctuations may enhance emotional sensitivity to psychosocial stress, leading to the development of a depressed mood. Women are at greater risk of depression than men, with rates doubling or tripling during the menopausal transition.
A new study from Johns Hopkins University School of Medicine demonstrates the effectiveness of a two-year menopause-focused curriculum for OB/GYN residents. The program improved residents' confidence in managing menopause patients, with 85.7% feeling comfortable or very comfortable after completion.
Postmenopausal women have more control over their body composition due to the effects of menopause, which can lead to weight gain and decreased physical activity. Regular exercise, even light physical activity such as walking or yard work, can improve body composition in postmenopausal women.